We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
-4.1%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$160M
AUM Growth
+$7.54M
Cap. Flow
+$24.6M
Cap. Flow %
15.33%
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CRBU icon
Caribou Biosciences
CRBU
+$16.5M
2
ILMN icon
Illumina
ILMN
+$8.13M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 86.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.8B
$96.9M 60.36%
2,680,644
– –
GDX icon
2
VanEck Gold Miners ETF
GDX
$27.6B
$21.8M 13.56%
738,500
– –
CRBU icon
3
Caribou Biosciences
CRBU
$165M
$16.1M 10.03%
+674,196
New +$16.5M
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.41B
$12.6M 7.85%
602,272
– –
ILMN icon
5
Illumina
ILMN
$29B
$6.97M 4.35%
+17,677
New +$8.13M
YMAB
6
DELISTED
Y-mAbs Therapeutics
YMAB
$6.19M 3.86%
216,916
– –

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q3 2021 Portfolio in Review

As of Q3 2021, Memorial Sloan Kettering Cancer Center held 6 positions worth $160M, up 4.9% from $153M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Memorial Sloan Kettering Cancer Center deployed $24.6M of net new capital in Q3 2021, opening 2 new positions. Its largest new stake was Caribou Biosciences: 674,196 shares worth $16.1M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 84% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's largest Q3 2021 buy was Caribou Biosciences: 674,196 shares worth $16.1M.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $160M portfolio in Q3 2021.
  • Memorial Sloan Kettering Cancer Center opened 2 new positions and closed 0 in Q3 2021.
  • Memorial Sloan Kettering Cancer Center's portfolio value rose 4.9% quarter-over-quarter to $160M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q3 2021, filed 15 Nov 2021.